Benefits of Otezla® (apremilast) for Psoriatic Arthritis
Indications
Approved Uses Otezla® (apremilast) is a prescription medicine used for the treatment of:
  • Adult patients with plaque psoriasis for whom phototherapy or systemic therapy is appropriate. Read more >
Approved Uses Otezla® (apremilast) is a prescription medicine used for the treatment of:
  • Adult patients with plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
  • Pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
  • Adult patients with active psoriatic arthritis.
  • Adult patients with oral ulcers associated with Behçet’s Disease. Read less >

Why consider Otezla

for psoriatic arthritis?

Otezla can help reduce symptoms after just 4 months. Talk to your doctor to see if it’s right for you.

Even minor joint aches can be a major pain—Otezla is a pill that can help

Everyone’s experience with psoriatic arthritis is different, and the same goes for treatment. Otezla can help reduce some of the symptoms of psoriatic arthritis in those it works for.

It’s been proven after just 4 months to:

  • Reduce joint swelling, tenderness, and pain
  • Improve the ability to perform physical activities of daily living

Joint
Otezla can help you achieve less joint swelling and tenderness.
SEE RESULTS
Swollen joints
Less joint pain is possible with Otezla.
SEE HOW
No blood tests for Otezla® (apremilast)
Some other medications for psoriatic arthritis require blood tests. Otezla does not.
READ ABOUT <br>OTEZLA SAFETY
More than 1 million Otezla® (apremilast) patients
More than 920,000 people have been treated with Otezla globally. Get to know just a few of these people just like you.
HEAR THEIR STORIES
Bicycle
Otezla could improve your ability to perform day-to-day physical activities.
FIND OUT HOW
Example of PDE4 inhibitor
Otezla works inside the body to reduce inflammation.
HOW DOES <br>OTEZLA WORK?
*Estimates of patients treated reflect global data since launch (Apr 2014-Sept 2023; US=57% of data). Calculations based on observed drug utilization parameters and number of units distributed. Utilization patterns change over time to best represent current markets.

I knew Otezla was working for me when I was able to get out of bed with less stiffness and pain.”

Cindy
Actual Otezla patient

Your results may vary

Woman preparing for a doctor's appointment

Prepare for your appointment

Communication is key. Start the conversation.

Pay as little as $0*

Did you know you may be eligible to pay as little as $0 per month through the Otezla Co-Pay Program? For eligible, commercially insured patients, your co-pay can be applied to deductible, co-insurance, and co-payment,* and is available regardless of your income level.

First-time co-pay card user? Find out more about how it works, and how it can help.

No insurance? Learn about other ways to access Otezla.

*For commercially insured patients only. Eligibility criteria and program maximums apply.
See AmgenSupportPlus.com/copay-terms for full Terms and Conditions.
Caregivers of kids and teens under 18 can contact Amgen® SupportPlus at
1-844-4OTEZLA (1-844-468-3952) to complete enrollment, Monday – Friday, 8 AM – 8 PM ET.
Hand holding copay card from Amgen® SupportPlus program
Hand holding copay card from Amgen® SupportPlus program
Woman on her laptop, in bed

Patient stories

Otezla has helped hundreds of thousands of people like you.

IMPORTANT SAFETY INFORMATION

You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

Otezla can cause allergic reactions, sometimes severe. Stop using Otezla and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing, raised bumps (hives), rash or itching, swelling of the face, lips, tongue, throat or arms.

Otezla can cause severe diarrhea, nausea, and vomiting, especially within the first few weeks of treatment. Use in elderly patients and the use of certain medications with Otezla appears to increase the risk of complications from having severe diarrhea, nausea, or vomiting. Tell your doctor if any of these conditions occur.

Otezla is associated with an increase in depression. In clinical studies, some patients reported depression, or suicidal behavior while taking Otezla. Some patients stopped taking Otezla due to depression. Before starting Otezla, tell your doctor if you have had feelings of depression, or suicidal thoughts or behavior. Be sure to tell your doctor if any of these symptoms or other mood changes develop or worsen during treatment with Otezla.

Some patients taking Otezla lost body weight. Your doctor should monitor your weight regularly. If unexplained or significant weight loss occurs, your doctor will decide if you should continue taking Otezla. For children 6 years of age or older, their doctor should monitor their growth (height and weight). If they are not growing or gaining weight as expected, their doctor will decide if they should continue taking Otezla.

Some medicines may make Otezla less effective and should not be taken with Otezla. Tell your doctor about all the medicines you take, including prescription and nonprescription medicines.

The most common side effects of Otezla include diarrhea, nausea, upper respiratory tract infection, tension headache, and headache. These are not all the possible side effects with Otezla. Ask your doctor about other potential side effects. Tell your doctor about any side effect that bothers you or does not go away.

Tell your doctor if you are pregnant, planning to become pregnant or planning to breastfeed.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-332-1088.

Please click here for the Full Prescribing Information for Otezla.

APPROVED USES

Otezla® (apremilast) is a prescription medicine used for the treatment of:

  • Adult patients with plaque psoriasis for whom phototherapy or systemic therapy is appropriate.
  • Pediatric patients 6 years of age and older and weighing at least 20 kg with moderate to severe plaque psoriasis who are candidates for phototherapy or systemic therapy.
  • Adult patients with active psoriatic arthritis.
  • Adult patients with oral ulcers associated with Behçet’s Disease.

IMPORTANT SAFETY INFORMATION

You must not take Otezla if you are allergic to apremilast or to any of the ingredients in Otezla.

Otezla can cause allergic reactions, sometimes severe. Stop using Otezla and call your healthcare provider or seek emergency help right away if you develop any of the following symptoms of a serious allergic reaction: trouble breathing or swallowing,